Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Opening of ATP sensitive potassium channels causes migraine attacks with aura

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Functional gene networks reveal distinct mechanisms segregating in migraine families

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Migraine

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Vestibular migraine: diagnostic criteria1

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The chronobiology of migraine: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The initiating mechanisms of migraine attacks are very complex but may involve the cyclic AMP signalling pathway. It is unknown whether intracellular cyclic AMP accumulation induces migraine attacks. We investigated whether administration of cilostazol, which causes cyclic AMP accumulation, may induce migraine attacks. We included 14 migraine patients without aura in a double-blind, placebo-controlled crossover study. All participants received oral cilostazol or placebo on two separate days. We recorded migraine headache characteristics, associated symptoms and time of rescue medication intake using a questionnaire. Cilostazol induced delayed migraine-like attacks in 12 patients (86%) compared with two (14%) patients after placebo (P = 0.002). The median time to onset for migraine-like attacks was 6 h (range 3-11 h). Patients reported that the attacks mimicked their usual migraine attacks and that cilostazol-induced attacks responded to their usual migraine treatment. Median time of medication intake was 6 h (range 4-11 h). The present study suggests that intracellular cyclic AMP accumulation plays a crucial role in migraine induction. This knowledge is a further step in our understanding of the intracellular pathway of migraine initiation.

OriginalsprogEngelsk
TidsskriftBrain
Vol/bind137
Udgave nummerPt 11
Sider (fra-til)2951-9
Antal sider9
ISSN0006-8950
DOI
StatusUdgivet - nov. 2014

ID: 45038753